These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2112982)

  • 21. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
    Nair S; Horton A; Leif RC; Krishan A
    Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
    Frankfurt OS
    J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
    Inaba M; Nagashima K
    Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA; Demidova NS; Shiriaeva OA; Shevtsova VN; Konovalova NP
    Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
    Krishan A; Sauerteig A; Gordon K; Swinkin C
    Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines.
    Deffie AM; Batra JK; Goldenberg GJ
    Cancer Res; 1989 Jan; 49(1):58-62. PubMed ID: 2535693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.
    McGown AT; Ward TH; Fox BW
    Cancer Chemother Pharmacol; 1983; 11(2):113-6. PubMed ID: 6627597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S; Samy TS; Krishan A
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells.
    Inaba M; Watanabe T; Sugiyama Y
    Jpn J Cancer Res; 1987 Apr; 78(4):397-404. PubMed ID: 3108219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
    Kessel D; Wilberding C
    Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
    Inaba M; Fujikura R; Sakurai Y
    Biochem Pharmacol; 1981 Jul; 30(13):1863-5. PubMed ID: 7271878
    [No Abstract]   [Full Text] [Related]  

  • 34. Anthracycline photoaffinity labeling of a mitochondrial polypeptide in P388 murine leukemic cell lines.
    Averbuch SD; Glover CJ; Felsted RL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6120-4. PubMed ID: 3465435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.
    Nair S; Singh SV; Samy TS; Krishan A
    Biochem Pharmacol; 1990 Feb; 39(4):723-8. PubMed ID: 2306280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative uptake of adriamycin and daunorubicin in sensitive and resistant friend leukemia cells measured by flow cytometry.
    Tapiero H; Fourcade A; Vaigot P; Farhi JJ
    Cytometry; 1982 Mar; 2(5):298-302. PubMed ID: 6951693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular accumulation and disposition of aclacinomycin A.
    Egorin MJ; Clawson RE; Ross LA; Schlossberger NM; Bachur NR
    Cancer Res; 1979 Nov; 39(11):4396-400. PubMed ID: 498071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
    Yanovich S; Preston L
    Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting.
    Ross DD; Ordóñez JV; Joneckis CC; Testa JR; Thompson BW
    Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.